EMIS.L

EMIS Group plc [EMIS.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?

EMIS.L Stock Summary

Earnings are expected to rise 8.56% next year

EMIS.L's dividend payments are not well covered by cash flows due to its high cash payout ratio (120.07%).

EMIS.L has less than 1 year of cash runway

In the News

EMIS.L Financial details

Company Rating

Strong Buy

Market Cap

1.23B

Income

22.44M

Revenue

162.15M

Book val./share

Cash/share

Dividend

0.42

Dividend %

0.02%

Employees

1.56K

Optionable

Shortable

Yes

Earnings

07 Sep 2023

P/E

36.58

Forward P/E

29.17

PEG

-16.32

P/S

7.03

P/B

8.52

P/C

P/FCF

31.53

Quick Ratio

0.65

Current Ratio

1.21

Debt / Equity

0.03

LT Debt / Equity

0.03

EPS (TTM)

0.36

EPS next Y

65.83

EPS next Q

EPS this Y

15.22%

EPS next Y

18344.94%

EPS next 5Y

18344.94%

EPS last 5Y

6.88%

Revenue last 5Y

0.62%

Revenue Q/Q

EPS Q/Q

SMA20

-0.13%

SMA50

5.39%

SMA100

41.48%

Inst Own

Inst Trans

ROA

15%

ROE

24%

ROC

0.18%

Gross Margin

93%

Oper. Margin

16%

Profit Margin

19%

Payout

67%

Shs Outstand

64.16M

Shs Float

62.04M

Target Price

52W Range

1250.0-1944.0

52W High

-1.23%

52W Low

+53.6%

RSI

63.14

Rel Volume

Avg Volume

929.13K

Volume

Perf Week

0.1%

Perf Month

0.21%

Perf Quarter

Perf Half Y

40.97%

Beta

-0.129

Volatility

0.99%, 5.79%

Prev Close

Price

1920

Change

-0.1%

EMIS.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	2.7	2.54	2.54	2.67	2.78
Net income per share	0.38	0.36	0.48	0.46	0.53
Operating cash flow per share	0.7	0.72	0.83	0.68	0.73
Free cash flow per share	0.49	0.51	0.68	0.57	0.62
Cash per share	0.25	0.49	0.84	1.02	0.73
Book value per share	1.62	1.65	1.9	2.04	2.26
Tangible book value per share	0.09	0.35	0.54	0.82	0.29
Share holders equity per share	1.62	1.65	1.9	2.04	2.26
Interest debt per share	0	0.07	0.12	0.1	0.08
Market cap	575.11M	696.78M	680.19M	856.47M	1.18B
Enterprise value	559.49M	669.61M	634.06M	798.35M	1.14B
P/E ratio	24.35	30.93	22.58	29.46	35.63
Price to sales ratio	3.38	4.37	4.27	5.09	6.74
POCF ratio	13.12	15.31	12.98	20.15	25.57
PFCF ratio	18.51	21.52	15.85	23.72	30.22
P/B Ratio	5.62	6.7	5.71	6.67	8.29
PTB ratio	5.62	6.7	5.71	6.67	8.29
EV to sales	3.29	4.2	3.98	4.75	6.5
Enterprise value over EBITDA	10.57	13.35	11.56	14.87	24.95
EV to operating cash flow	12.77	14.72	12.1	18.78	24.67
EV to free cash flow	18.01	20.68	14.78	22.11	29.16
Earnings yield	0.04	0.03	0.04	0.03	0.03
Free cash flow yield	0.05	0.05	0.06	0.04	0.03
Debt to equity	0	0.04	0.06	0.05	0.03
Debt to assets	0	0.02	0.04	0.03	0.02
Net debt to EBITDA	-0.3	-0.54	-0.84	-1.08	-0.91
Current ratio	0.88	1.21	1.38	1.64	1.21
Interest coverage	115.42	45.09	60.64	75.18	52.25
Income quality	1.5	1.67	1.42	1.18	1.19
Dividend Yield	0.03	0.03	0.03	0.02	0.02
Payout ratio	0.72	0.83	0.66	0.73	0.67
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.57	0.49	0.44	0.39	0.55
Capex to operating cash flow	-0.29	-0.29	-0.18	-0.15	-0.15
Capex to revenue	-0.08	-0.08	-0.06	-0.04	-0.04
Capex to depreciation	-0.54	-0.58	-0.55	-0.37	-0.42
Stock based compensation to revenue	0	0.01	0.01	0.01	0.01
Graham number	3.7	3.65	4.52	4.6	5.17
ROIC	0.23	0.2	0.22	0.21	0.16
Return on tangible assets	0.32	0.26	0.28	0.24	0.33
Graham Net	-0.83	-0.52	-0.32	-0.07	-0.57
Working capital	-7.06M	11.58M	23.8M	39.69M	14.86M
Tangible asset value	5.85M	21.85M	33.84M	51.94M	18.28M
Net current asset value	-15.26M	3.11M	13.62M	32.89M	3.28M
Invested capital	0	0.04	0.06	0.05	0.03
Average receivables	0	0	0	0	0
Average payables	22.58M	24.2M	27.33M	30.2M	31.68M
Average inventory	1.45M	960.5K	635K	571.5K	524K
Days sales outstanding	0	0	0	0	0
Days payables outstanding	620.3	555.23	560.36	655.23	966.89
Days of inventory on hand	31.41	15.56	11	11.9	14.66
Receivables turnover	0	0	0	0	0
Payables turnover	0.59	0.66	0.65	0.56	0.38
Inventory turnover	11.62	23.45	33.17	30.67	24.91
ROE	0.23	0.22	0.25	0.23	0.23
Capex per share	-0.2	-0.21	-0.15	-0.1	-0.11

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric	2021-06-30	2021-12-31	2022-06-30	2022-12-31	2023-06-30
	2.02K	2.02K	2.02K	2.02K	2.02K
Revenue per share	0	0	0	0	0
Net income per share	0	0	0	0	0
Operating cash flow per share	0	0	0	0	0
Free cash flow per share	0	0	0	0	0
Cash per share	0	0	0	0	0
Book value per share	0	0	0	0	0
Tangible book value per share	0	0	0	0	0
Share holders equity per share	0	0	0	0	0
Interest debt per share	0	0	0	0	0
Market cap	0	0	0	0	0
Enterprise value	-41.78M	-58.13M	-48.22M	-41.55M	-44.58M
P/E ratio	0	0	0	0	0
Price to sales ratio	0	0	0	0	0
POCF ratio	0	0	0	0	0
PFCF ratio	0	0	0	0	0
P/B Ratio	0	0	0	0	0
PTB ratio	0	0	0	0	0
EV to sales	0	0	0	0	0
Enterprise value over EBITDA	0	0	0	0	0
EV to operating cash flow	0	0	0	0	0
EV to free cash flow	0	0	0	0	0
Earnings yield	0	0	0	0	0
Free cash flow yield	0	0	0	0	0
Debt to equity	0.05	0.05	0.04	0.03	0.03
Debt to assets	0.03	0.03	0.02	0.02	0.02
Net debt to EBITDA	0	0	0	0	0
Current ratio	1.4	1.64	1.31	1.21	1.07
Interest coverage	0	0	0	0	0
Income quality	0	0	0	0	0
Dividend Yield	0	0	0	0	0
Payout ratio	0	0	0	0	0
Sales general and administrative to revenue	0	0	0	0	0
Research and developement to revenue	0	0	0	0	0
Intangibles to total assets	0.41	0.39	0.46	0.55	0.51
Capex to operating cash flow	0	0	0	0	0
Capex to revenue	0	0	0	0	0
Capex to depreciation	0	0	0	0	0
Stock based compensation to revenue	0	0	0	0	0
Graham number	0	0	0	0	0
ROIC	0	0	0	0	0
Return on tangible assets	0	0	0	0	0
Graham Net	0	0	0	0	0
Working capital	27.81M	39.69M	24.34M	14.86M	7.04M
Tangible asset value	39.84M	51.94M	29.26M	18.28M	11.3M
Net current asset value	20.17M	32.89M	12.29M	3.28M	-1.53M
Invested capital	0.05	0.05	0.04	0.03	0.03
Average receivables	0	0	0	0	0
Average payables	0	0	0	0	0
Average inventory	0	0	0	0	0
Days sales outstanding	0	0	0	0	0
Days payables outstanding	0	0	0	0	0
Days of inventory on hand	0	0	0	0	0
Receivables turnover	0	0	0	0	0
Payables turnover	0	0	0	0	0
Inventory turnover	0	0	0	0	0
ROE	0	0	0	0	0
Capex per share	0	0	0	0	0

EMIS.L Dividend History

EMIS.L Frequently Asked Questions

What is EMIS Group plc stock symbol ?

EMIS Group plc is a GB stock and trading under the symbol EMIS.L

What is EMIS Group plc stock quote today ?

EMIS Group plc stock price is $1920 today.

Is EMIS Group plc stock public?

Yes, EMIS Group plc is a publicly traded company.

Something similar

Top by Market Cap

Same Sector

Same Price Range

Similar Market Cap

Company Profile

Volume Average 929.13K
Market Capitalization 1.23B
Employee 1.56K
CEO Mr. Andrew John Thorburn
Headquarters Leeds,GB
IPO Date 2010-03-29
Website https://www.emisgroupplc.com

EMIS Group plc, through its subsidiaries, provides connected healthcare software and systems for healthcare professionals in the United Kingdom. It operates in two segments, EMIS Health and EMIS Enterprise. The EMIS Health segment supplies integrated care technology to national health service markets, including primary, community, acute, and social care. The EMIS Enterprise segment focuses on the B2B technology sector in the healthcare market, such as management of medicines, partner businesses, life sciences, and patient-facing services. The company offers clinical software to healthcare organizations under the EMIS brand; patient-centric medical and wellbeing information and digital front door services under the Patient brand name; GP appraisals and training services; and service management solutions to the community pharmacy market under the Pinnacle brand, as well as business intelligence tools for GP practices, federations, and commissioners. It also operates Patient.info, an online health platform that provides personalized online patient-facing services and healthcare content; Patient Access and EMIS Web, which enables patients to order repeat medication online and track progress from order to home delivery; and ProScript and ProScript Connect, which enable pharmacies to manage the dispensing process and handle tasks, such as labeling and endorsing, patient records, ordering, and stock control. In addition, the company provides non-clinical ICT solutions for healthcare professionals and other public and private sector organizations; and supplies ICT infrastructure and hosting services. The company was founded in 1987 and is headquartered in Leeds, the United Kingdom.